(Boston) – Researchers from Boston University’s Center for Regenerative Medicine (CReM) have demonstrated that induced pluripotent stem cells (iPSCs) can differentiate into definitive endoderm cells, in vitro, with similar functional potential when compared to embryonic stem cells (ESCs), despite minor molecular differences between the two cell types
Related articles
- Disease in a Dish Model Now Increasingly Used by Scientists (medindia.net)
- From patient stem cells to potential treatment strategy in Lou Gehrig’s disease (medicalnewstoday.com)
- Policy paper: Regenerative medicine inquiry: government response (gov.uk)
- Researchers in Israel Discovered the “Brake” Mechanism In iPS Stem Cell Reproduction – A Breakthrough for Regenerative Medicine (ducknetweb.blogspot.com)
trans-bio-tex.com 